Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Cardiology/Vascular Diseases

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Warfarin Sodium tablets

Company: Barr Laboratories
Approval Status: Approved March 1997
Treatment Area: Anticoagulant, or "blood thinner" to keep blood clots from forming or getting larger

General Information

Seven strengths of Warfarin Sodium tablets, the generic equivalent of DuPont Merck’s anti-coagulant Coumadin, have been approved for marketing.


Jobson Medical Information

Copyright © 1995-2010 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.